Dr. David Harpole, Duke University Medical Center, details the methods thoracic surgeons use to assess a patient's fitness for surgery.
Dr. David Harpole, Duke University Medical Center, describes how he assists patients with the surgical decision-making process.
Dr. Nasser Hanna, Indiana University Health, addresses the issue of prophylactic cranial irradiation (PCI) in locally advanced NSCLC.
Dr. Nasser Hanna, Indiana University Health, discusses the possible role of immunotherapy in locally advanced NSCLC.
Dr. Nasser Hanna, Indiana University Health, lists chemo regiments appropriate for use with radiation in locally advanced NSCLC.
Dr. Phil Bonomi, from Rush University, offers his insights on how to approach a patient with gradual progression in a single site, especially in the...
Dr. David Spigel, Sarah Cannon Cancer Center, discusses his perspective on side effects of targeted therapies as compared with standard chemotherapy...
Dr. Rosalyn Juergens, McMaster University, discusses the question of widespread availability of new mutation tests under the Canadian health care...
Dr. Sarah Goldberg from Yale Cancer Center describes which molecular markers she seeks for NSCLC patients. [powerpress]
Earlier this week, the FDA approved the oral epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) Tarceva (erlotinib) for the...
Hi, My brother diagnosed Mar 2013 NSCLC IV ALK+. Cis/ Alimta then Alimta maintainance. Xalkori. Ceritinib,. WBR October 2017 because of LMD, straight...
I wish to seek advice please re the following. My elderly relative, 89 yrs old femaie ex smoker, has a pulmonary nodule of 6 mm which is deemed...
1. I am an early retired CPA and former equity partner (64) from Denmark and despite my education I should start from scratch when I should try to...
I have an autoimmune disease, Sjogrens. I also have a Pulmonary issue called Chronic Eosinophilic Pneumonitis caused by Sjogrens causing shortness of...
Dear Doctors ,please help me to define the right treatment ! I was just diagnosed with NSCLC adenocarcinoma that is poorly differentiated (CK7...
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.